[Journal logo]

Volume 65 
Part 5 
Page o986  
May 2009  

Received 28 March 2009
Accepted 31 March 2009
Online 8 April 2009

Key indicators
Single-crystal X-ray study
T = 296 K
Mean [sigma](C-C) = 0.003 Å
R = 0.029
wR = 0.083
Data-to-parameter ratio = 16.2
Details
Open access

2-(3-Methylbut-2-en-1-yl)-1,2-benzisothiazol-3(2H)-one 1,1-dioxide

aDepartment of Chemistry, Government College University, Lahore, Pakistan, and bDepartment of Physics, University of Sargodha, Sargodha, Pakistan
Correspondence e-mail: dmntahir_uos@yahoo.com

In the title compound, C12H13NO3S, a saccharin derivative, the dihedral angle between the aromatic and isothiazole rings is 2.91 (12)°. The planar 3,3-dimethylallyl group [maximum deviation = 0.0086 (16) Å] is oriented at dihedral angles of 71.86 (7) and 74.35 (7)° with respect to the aromatic and isothiazole rings, respectively. In the crystal structure, weak intermolecular C-H...O interactions link the molecules into chains along the c axis. A weak C-H...[pi] interaction is also present.

Related literature

For the biological activity of saccharine derivatives, see: Primofiore et al. (1997[Primofiore, G., Da Settimo, F., La Motta, C., Simorini, F., Minutolo, A. & Boldrini, E. (1997). Farmaco, 52, 583-588.]). For related structures, see: Arshad et al. (2008[Arshad, M. N., Tahir, M. N., Khan, I. U., Shafiq, M. & Siddiqui, W. A. (2008). Acta Cryst. E64, o2045.]); Kruszynski & Czestkowski (2001[Kruszynski, R. & Czestkowski, W. (2001). Acta Cryst. E57, o516-o518.]); Siddiqui et al. (2007[Siddiqui, W. A., Ahmad, S., Khan, I. U., Siddiqui, H. L. & Parvez, M. (2007). Acta Cryst. E63, o4116.]); Yu et al. (2008[Yu, G.-P., Xu, Z.-J., Xu, L.-Z. & Aisa, H. A. (2008). Acta Cryst. E64, o805.]). For bond-length data, see: Allen et al. (1987[Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.]).

[Scheme 1]

Experimental

Crystal data
  • C12H13NO3S

  • Mr = 251.29

  • Orthorhombic, P n a 21

  • a = 9.4120 (5) Å

  • b = 19.4108 (11) Å

  • c = 6.5261 (4) Å

  • V = 1192.28 (12) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.27 mm-1

  • T = 296 K

  • 0.32 × 0.24 × 0.22 mm

Data collection
  • Bruker Kappa APEXII CCD area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2005[Bruker (2005). SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.924, Tmax = 0.946

  • 7340 measured reflections

  • 2525 independent reflections

  • 2304 reflections with I > 2[sigma](I)

  • Rint = 0.019

Refinement
  • R[F2 > 2[sigma](F2)] = 0.029

  • wR(F2) = 0.083

  • S = 1.05

  • 2525 reflections

  • 156 parameters

  • 1 restraint

  • H-atom parameters constrained

  • [Delta][rho]max = 0.28 e Å-3

  • [Delta][rho]min = -0.20 e Å-3

  • Absolute structure: Flack (1983[Flack, H. D. (1983). Acta Cryst. A39, 876-881.]), 837 Friedel pairs

  • Flack parameter: 0.02 (8)

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
C5-H5...O1i 0.93 2.56 3.391 (2) 149
C8-H8A...O2ii 0.97 2.51 3.436 (3) 160
C3-H3...Cg1iii 0.93 2.89 3.664 (2) 141
Symmetry codes: (i) [-x+1, -y+1, z+{\script{1\over 2}}]; (ii) x, y, z-1; (iii) [x+{\script{1\over 2}}, -y+{\script{1\over 2}}, z]. Cg1 is the centroid of the C1-C6 ring.

Data collection: APEX2 (Bruker, 2007[Bruker (2007). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2007[Bruker (2007). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]) and PLATON (Spek, 2009[Spek, A. L. (2009). Acta Cryst. D65, 148-155.]); software used to prepare material for publication: WinGX publication routines (Farrugia, 1999[Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.]) and PLATON.


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HK2656 ).


Acknowledgements

MNA greatfully acknowledges the Higher Education Commission, Islamabad, Pakistan, for providing him with a Scholaship under the Indigenous PhD Program (PIN 042-120607-PS2-183).

References

Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Arshad, M. N., Tahir, M. N., Khan, I. U., Shafiq, M. & Siddiqui, W. A. (2008). Acta Cryst. E64, o2045.  [CSD] [CrossRef] [details]
Bruker (2005). SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Bruker (2007). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.  [CrossRef] [ChemPort] [details]
Flack, H. D. (1983). Acta Cryst. A39, 876-881.  [CrossRef] [details]
Kruszynski, R. & Czestkowski, W. (2001). Acta Cryst. E57, o516-o518.  [CSD] [CrossRef] [details]
Primofiore, G., Da Settimo, F., La Motta, C., Simorini, F., Minutolo, A. & Boldrini, E. (1997). Farmaco, 52, 583-588.  [ChemPort] [PubMed]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Siddiqui, W. A., Ahmad, S., Khan, I. U., Siddiqui, H. L. & Parvez, M. (2007). Acta Cryst. E63, o4116.  [CSD] [CrossRef] [details]
Spek, A. L. (2009). Acta Cryst. D65, 148-155.  [ISI] [CrossRef] [details]
Yu, G.-P., Xu, Z.-J., Xu, L.-Z. & Aisa, H. A. (2008). Acta Cryst. E64, o805.  [CSD] [CrossRef] [details]


Acta Cryst (2009). E65, o986  [ doi:10.1107/S1600536809012021 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.